Cochlear Limited
CHEOF
$193.88
-$8.81-4.35%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.52B | 1.52B | 1.52B | 1.50B | 1.47B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.52B | 1.52B | 1.52B | 1.50B | 1.47B |
| Cost of Revenue | 398.12M | 387.40M | 378.60M | 374.69M | 368.59M |
| Gross Profit | 1.12B | 1.13B | 1.14B | 1.12B | 1.10B |
| SG&A Expenses | 608.67M | 611.57M | 617.28M | 604.74M | 588.72M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -17.06M | -14.13M | -11.29M | -9.20M | -7.02M |
| Total Operating Expenses | 1.18B | 1.18B | 1.18B | 1.16B | 1.13B |
| Operating Income | 338.91M | 341.08M | 344.76M | 340.46M | 334.17M |
| Income Before Tax | 336.24M | 332.73M | 330.68M | 325.28M | 317.84M |
| Income Tax Expenses | 84.10M | 84.97M | 86.18M | 85.31M | 83.92M |
| Earnings from Continuing Operations | 252.14 | 247.76 | 244.50 | 239.97 | 233.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 252.14M | 247.76M | 244.50M | 239.97M | 233.92M |
| EBIT | 338.91M | 341.08M | 344.76M | 340.46M | 334.17M |
| EBITDA | 372.30M | 372.80M | 374.84M | 370.30M | 363.44M |
| EPS Basic | 3.85 | 3.78 | 3.73 | 3.66 | 3.57 |
| Normalized Basic EPS | 3.23 | 3.28 | 3.34 | 3.29 | 3.21 |
| EPS Diluted | 3.84 | 3.77 | 3.72 | 3.65 | 3.56 |
| Normalized Diluted EPS | 3.22 | 3.27 | 3.33 | 3.28 | 3.21 |
| Average Basic Shares Outstanding | 261.75M | 261.84M | 261.93M | 262.04M | 262.15M |
| Average Diluted Shares Outstanding | 262.42M | 262.57M | 262.71M | 262.80M | 262.88M |
| Dividend Per Share | 2.78 | 2.79 | 2.80 | 2.75 | 2.69 |
| Payout Ratio | 71.44% | 71.93% | 72.46% | 70.71% | 68.90% |